Role of anion transporters in the regulation of PMN chemotaxis

阴离子转运蛋白在中性粒细胞趋化性调节中的作用

基本信息

  • 批准号:
    8050649
  • 负责人:
  • 金额:
    $ 12.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-01 至 2013-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of this proposal is to foster the career development of Dr. A. Paige Volk while undertaking the investigation of a fundamental component of innate host defense, neutrophil (PMN) chemotaxis, i.e. directed motility. Dr. Volk's long term career goal is become an independent physician-scientist with the education, research skills and experience necessary to make a significant contribution to bio-medical science. Her more short-term goals are: 1) to advance Dr. Volk's expertise in cellular and molecular immunology through both coursework and molecular biological experimentation; and 2) to define mechanisms by which anion transporters and oxidants regulate PMN chemotaxis. Dr. Volk's career development would take place in the nurturing environment of the NIH-supported Inflammation Program, with Dr. Jessica Moreland as her mentor, and Dr. Fred Lamb as co-mentor. This environment provides Dr. Volk full access to the resources and scientific expertise required to make a significant contribution to the study of innate host defense. Dr. Volk began to investigate the role of the anion transporter, ClC-3, in PMN function after mice lacking this protein demonstrated impaired innate immunity and deficits in PMN function. The hypothesis of this proposal is that cell volume regulation via the swelling-induced chloride current, IClswell, is mediated by oxidant signaling and required for chemotaxis to select stimuli. This hypothesis will be addressed with the following aims: 1) To characterize mechanisms of cell volume regulation in PMN chemotaxis; and 2) To characterize the oxidant-sensitive signaling interactions that distinguish chemotaxis to select stimuli and determine the role of ClC-3 in this process. To explore these aims a combination of molecular analyses and functional assays of human and murine PMN will be used. Localized volume changes and chloride movement will be studied using advanced 2D/3D microscopic image analysis, confocal fluorescence microscopy and electrophysiology techniques. Regulation of chemotaxis signaling pathways by ClC-3- modulated oxidants will be assessed by confocal microscopy and flow cytometry using a novel competitive chemotaxis assay. The role of ClC-3 and intracellular oxidants in chemotaxis will be studied in vivo using advanced two-photon intravital microscopy techniques. This proposal is highly innovative in that we will elucidate a previously unappreciated role for intracellular oxidants in chemotaxis signaling. The requirement for normal PMN function in the innate immune response during sepsis has been demonstrated unequivocally and the anion transporters ClC-3 and IClswell are required for normal PMN chemotaxis. Uncontrolled PMN activation and migration into healthy tissues during severe sepsis leads to multiple organ system dysfunction. The current project will significantly advance the understanding of neutrophil migration mechanisms that can ultimately be translated into therapeutic strategies to reduce the burden of illness and disability due to sepsis
描述(由申请人提供):本提案的目标是促进 A. Paige Volk 博士的职业发展,同时研究宿主先天防御的基本组成部分——中性粒细胞 (PMN) 趋化性,即定向运动。 Volk 博士的长期职业目标是成为一名独立的医师科学家,拥有为生物医学做出重大贡献所需的教育、研究技能和经验。她的短期目标是:1)通过课程作业和分子生物学实验来提高 Volk 博士在细胞和分子免疫学方面的专业知识; 2) 确定阴离子转运蛋白和氧化剂调节 PMN 趋化性的机制。 Volk 博士的职业发展将在 NIH 支持的炎症项目的培育环境中进行,杰西卡·莫兰博士 (Jessica Moreland) 担任她的导师,弗雷德·兰姆 (Fred Lamb) 博士担任联合导师。这种环境使 Volk 博士能够充分获取所需的资源和科学专业知识,为宿主先天防御的研究做出重大贡献。在缺乏阴离子转运蛋白 ClC-3 的小鼠表现出先天免疫受损和中性粒细胞功能缺陷后,Volk 博士开始研究阴离子转运蛋白 ClC-3 在中性粒细胞功能中的作用。该提议的假设是,通过肿胀诱导的氯电流 IClswell 进行的细胞体积调节是由氧化剂信号介导的,并且是趋化性选择刺激所必需的。该假设将通过以下目标来解决:1)表征中性粒细胞趋化性中细胞体积调节的机制; 2) 表征氧化剂敏感信号相互作用,区分趋化性以选择刺激并确定 ClC-3 在此过程中的作用。为了探索这些目标,将结合使用人和鼠 PMN 的分子分析和功能测定。将使用先进的 2D/3D 显微图像分析、共焦荧光显微镜和电生理学技术来研究局部体积变化和氯离子运动。 ClC-3 调节的氧化剂对趋化信号通路的调节将通过共聚焦显微镜和流式细胞术使用新型竞争性趋化性测定进行评估。将使用先进的双光子活体显微镜技术在体内研究 ClC-3 和细胞内氧化剂在趋化性中的作用。 This proposal is highly innovative in that we will elucidate a previously unappreciated role for intracellular oxidants in chemotaxis signaling. 脓毒症期间先天免疫反应对正常 PMN 功能的要求已被明确证明,并且阴离子转运蛋白 ClC-3 和 IClswell 是正常 PMN 趋化性所必需的。严重脓毒症期间不受控制的 PMN 激活和迁移到健康组织会导致多器官系统功能障碍。当前的项目将显着增进对中性粒细胞迁移机制的理解,最终可以转化为治疗策略,以减轻脓毒症引起的疾病和残疾负担

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexandra Paige Davis Volk其他文献

Alexandra Paige Davis Volk的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alexandra Paige Davis Volk', 18)}}的其他基金

Role of anion transporters in the regulation of PMN chemotaxis
阴离子转运蛋白在中性粒细胞趋化性调节中的作用
  • 批准号:
    7893266
  • 财政年份:
    2010
  • 资助金额:
    $ 12.78万
  • 项目类别:
Role of anion transporters in the regulation of PMN chemotaxis
阴离子转运蛋白在中性粒细胞趋化性调节中的作用
  • 批准号:
    8240412
  • 财政年份:
    2010
  • 资助金额:
    $ 12.78万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 12.78万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.78万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 12.78万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.78万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 12.78万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 12.78万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.78万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 12.78万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 12.78万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.78万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了